Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2430 (LINC02430) is a human long non-coding RNA (lncRNA) gene, classified as a long intergenic non-protein coding RNA[1][5]. It does not code for a functional protein but is a member of a broad family of lincRNAs, which are RNA molecules over 200 nucleotides in length and are transcribed from regions of the genome that do not overlap with protein-coding genes[3]. The specific biological function, disease involvement, and roles as a biomarker or therapeutic target have not been described for LINC02430. While the broader family of lincRNAs is known to play roles in fine-tuning gene expression, chromatin remodeling, and transcription regulation[3][7], there is no evidence currently that LINC02430 has a defined or validated role in these processes. No drugs are known to interact with LINC02430, and it is not considered a therapeutic target based on current knowledge[1][5].
Not applicable (no drugs target this molecule)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2430 (LINC02430).